A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months

Abstract Background To evaluate the long-term efficacy and safety of fremanezumab over a 2-year period in a real-world setting. Methods This retrospective, observational, single-center cohort study included 165 patients with episodic migraine (EM) or chronic migraine (CM) who received fremanezumab t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Neurological Research and Practice
المؤلفون الرئيسيون: Shiho Suzuki, Keisuke Suzuki, Yasuo Haruyama, Hiroaki Fujita, Tomohiko Shiina, Saro Kobayashi, Mukuto Shioda, Ryotaro Hida, Koichi Hirata
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2025-06-01
الموضوعات:
Migraine
Migraine days per month
Fremanezumab
Calcitonin gene-related peptide monoclonal antibody
الوصول للمادة أونلاين:https://doi.org/10.1186/s42466-025-00395-y

الانترنت

https://doi.org/10.1186/s42466-025-00395-y

مواد مشابهة